
Preliminary studies presented Tuesday at the International Society for Magnetic Resonance in Medicine meeting in Berlin gave radiologists a glimpse of future imaging practices for cancer patients: a molecular nuclear imaging test to assess the extent of hypoxia and functional MRI to monitor the response of head and neck carcinoma to treatment.























